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Accessory cell functions in mononuclear cell cultures from uremic
patients. Mononuclear cells (PBMC) were isolated from dialyzed pa-
tients and healthy control subjects. Lymphocyte responses to stimula-
tion with optimal and suboptimal concentrations of lectin (PHA), or
stimulation with T cell receptor antibody (Leu 4) were found decreased
in the patient cultures. The separate and the combined effects of
exogenous interleukin-l (IL-l) and interleukin-2 (IL-2) were examined
in PHA and Leu 4 stimulated cell cultures. Addition of IL-l did not
normalize the decreased proliferation response of the patient cultures.
In contrast, addition of IL-2 alone clearly enhanced and almost normal-
ized the response of patient cultures stimulated with suboptimal con-
centrations of PITA. The combined addition of IL-I and IL-2 gave no
evidence of an additive effect of IL-i and IL-2. Cell cultures from
uremic and normal HLA-identical relative were examined. Substitution
of uremic adherent monocytes with normal adherent monocytes as
accessory cells did not improve the uremic T cell responses to stimu-
lation with PITA. Furthermore, uremic adherent cells did not suppress
the normal T cell responses, These results suggest that uremic acces-
sory cells support T cell activation and, in particular, do not suppress T
cell responses. The effect of IL-2 in the present study as well as
previous findings of decreased IL-2 production in patients cultures may
indicate that uremia primarily influences the proliferation of T cells.
In uremia a decreased immune response has been found in
vivo [1, 2] and in vitro [3—6]. In vitro studies have shown that
stimulated mononuclear cell cultures from hemodialyzed pa-
tients produce less interleukin-2 (IL-2) than normal cell cul-
tures, whereas the expression of IL-2 receptors is unchanged or
increased [6]. Activation of T cells is initiated by accessory cells
which produce interleukin-l (IL-i) and present lectins or anti-
gens in the context of class II MHC products. Monocytes/
macrophages are the most important accessory cells [7, 8].
Thus, impaired accessory cell function in uremia could be a
possible mechanism for the decreased proliferation of uremic
lymphocyte cultures. Therefore, the present study was under-
taken to examine accessory cell functions in uremic patients.
Methods
Subjects
Peripheral venous blood was obtained before start of hemo-
dialysis from 12 patients (4 females, 8 males) and from 12 (5
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females, 7 males) age-matched control subjects. All patients
had been on hemodialysis for at least one year and all had
received blood transfusion. Predialysis blood samples were also
obtained from nine uremic patients (2 females, 7 males) on
hemodialysis and their healthy HLA-DR identical and mixed
lymphocyte culture (MLC) negative relatives, either siblings or
parents prior to kidney donation.
Patients and control subjects had no signs or symptoms of
malignant diseases, inflammatory diseases, or were receiving
immunosuppressive therapy.
Mitogen and antigen stimulated proliferation
Peripheral blood mononuclear cells (PBMCs) were isolated
from the blood samples as previously described [5, 6].
Triplicates of 5 x iO PBMCs were cultured in microtiter
plates (Nunc, Denmark) in a total volume of 170 p1. Phytohe-
magglutinin (PHA-P, Difco, Detroit, Michigan, USA) was used
as lectin in the cultures in optimal (40 g/ml culture) and
suboptimal (2 g/ml culture) concentrations. Leu 4 (anti-CD3)
was used for direct stimulation of lymphocyte cultures at
concentrations with maximal stimulatory effect found by titra-
tion (Leu 4; Becton Dickinson, Pennsylvania, USA, 1:20, 20
p1Iwell). Lectin and Leu 4 stimulated cultures were incubated
72 hours in a humidified atmosphere with 5% carbon dioxide at
37° before 20-hour pulsing of the cultures with '4C-thymidine
('4C-thymidine, 20 nCi/well, Amersham, UK) and harvested.
Part of the cultures was in parallel experiment supplemented
with 1.25, 2.5 and 5 U/mI culture of purified human interleukin- 1
(interleukin- 1; Koch Light Ldt., UK) or purified human inter-
leukin-2 (interleukin-2, Electronucleonics Inc., Maryland,
USA, 10 p1Iwell, or approximately 100 U).
Furthermore, six cultures from uremic patients and six con-
trols were supplemented with normal erythrocytes. The eryth-
rocytes were washed three times with saline and added to the
culture to a final hematocrit of 1.5% in the culture medium
before the PHA stimulation.
Isolation of cells for coculture experiments
Isolated PBMCs from nine patients and nine HLA-identical
relatives were used in coculture experiment. Monocytes were
obtained by two hour adherence in RPMI 1640 (Gibco) with
10% fetal calf serum (FCS) to plastic culture dishes. The
adherent monocytes were detached from plastic after incuba-
tion for 30 minutes on ice and rinsed off the plates by ice-cold
RPMI-1640 with 10% FCS. The nonadherent cell fraction was
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further purified twice over nylon wool columns to obtain a
T-cell enriched cell fraction depleted of monocytes/macro-
phages [9]. T-cell enriched normal and uremic cell isolates (5 X
iø cells/well) were then cultured in the presence of 1% and 5%
(500 and 2500 cells) normal or uremic adherent cells as acces-
sory cells. As control 2.5 x iO normal and 2.5 x lO uremic
PBMCs were cocultured. PHA was used at optimal (40 g/ml
cell culture) and suboptimal (2 g/ml cell culture) concentra-
tions. The culture conditions were as described above.
Esterase staining of monocytes/macrophages
Esterase staining was done as described by Tucker, Pierre
and Jordan 1977 [10]. In one tube six drops of 1 mg% basic
fuchsin (T0l-0529, Technicon Instruments Corporation, New
York, USA) was added to six drops of 7% sodium nitrite
(T0l-0530) to form the unstable hexazonium pararosanilin.
Eighteen drops of 7% sodium cacodylate (TO 1-0531; buffer and
serum lipase inhibitor) were added followed by three drops of
alfa-naphtyl butyrat (T01-0680-81) as substrate. In a second
tube, two drops of cells and two drops of fetal calf serum were
mixed and added. The cells were then fixed for 40 seconds
(fixative: 478.5 g diethylenglycol, 50 ml formaldehyde, 10.9 g
sodium acetate, and 0.6 g eserin sulphate in 1 liter distilled
water). The contents of the second tube was then added to the
first tube and incubated for two to three hours at 37°C before
microscopic counting of dark red cells.
Statistical analysis
Student's t-test was used for comparison between groups. P
values <0.05 were considered significant.
Results
Patient PBMCs stimulated with optimal concentrations of
PHA (40 gIml) responded significantly lower than the control
cultures. IL-i, IL-2, or IL-l together with IL-2 (Fig. 1) had no
additional effect on the response of the control cultures and did
not enhance the response of the patient PBMCs. Suboptimal
PHA stimulation (2 iLg/ml) of the patient PBMC cultures
induced lower responses than in the control cultures (P < 0.05;
Fig. 2). Addition of IL-l alone improved patient as well as
control PBMC responses, but the effect did not reach signifi-
cance. In contrast, addition of IL-2 clearly enhanced both
control and patient culture proliferation (P < 0.01) and de-
creased the difference between the two responses. No additive
effects of IL-2 and IL-i were observed. Results of stimulation
with Leu 4 alone (Fig. 3) were comparable with those of
suboptimal PHA stimulation. IL-l alone had no effect on
patient and control cultures, whereas IL-2 improved the PBMC
responses (P < 0.05) in both uremic and control cultures. The
PHA-2 and Leu 4 responses of uremic cell cultures with
exogenous IL-2 were not significantly different from the normal
cell cultures without exogenous IL-2 (F> 0.1).
Figure 4 shows the results of addition of erythrocytes to the
culture medium. Addition of erythrocytes to the cultures im-
proved the mitogen responses of patient and control cultures by
about 20%, but did not normalize the decreased responses of
the uremic cell cultures. The percentage of esterase positive
cells (macrophages) was similar in patient and control PBMC
cultures (11.6 1.1% [sEM], and 13.3 1.5%, N = 11, P >
0.05). In the coculture experiments, the mixed lymphocyte
culture (MLC) responses were 1% of those obtained by PHA-
stimulation, confirming the HLA-D identity between the nine
patients and the nine healthy donors [11]. Stimulation of the
patient and control PBMC cultures with 40 or 2 g/ml PHA
showed slightly lower responses of the uremic cell cultures, but
the difference did not reach significance in this small material.
However, there was a significant difference in the responses to
2 g/ml PHA in the T-cell enriched fractions when normal and
uremic patient cultures were compared (Fig. 5). Five percent
adherent cells from patients or controls equally well enhanced T
cell proliferation at suboptimal PHA concentrations (2 jgIml,
Fig. 5) and the same pattern was seen with PHA 40, but
significant only for normal T cells (Fig. 6). Furthermore, there
was no evidence that uremic adherent cells suppressed normal






















Fig. 1. Mean '4C-thymidine uptake of 5 x io
— 0 peripheral blood mononuclear cells (PBMCs)
stimulated with optimal concentrations of
+ PHA (40 g/ml). Symbols are () uremicPBMC cultures (N = 12), () normal PBMC
cultures (N = 12). Vertical lines indicate SEM.PHA 40, g/m/
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Fig. 2. Mean '4C-thymidine uptake of 5 X 1O
— 0 peripheral blood mononuclear cells (PBMCs)
+ — + + + + stimulated with suboptimal concentrations of5 5 0 1.25 2.5 PHA (2 p.g/ml). Symbols are: () uremic+ + + PBMC cultures (N = 11); (D) normal PBMC
PHA2, jg/m/ cultures (N = 11). Vertical lines indicate SEM.
0
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bulk PBMCs could be demonstrated when cocultured with
normal bulk PBMCs.
Discussion
Previous studies [4, 5] have shown that PBMC cultures
isolated from uremic patients respond lower than normal cul-
tures to lectin stimulation as measured by DNA synthesis and
production of IL-2. Expression of receptors for IL-2 has,
however, been found normal in PHA-stimulated lymphocyte
cultures from uremic patients [6] and cytotoxic effector cell
functions that do not require cell proliferation remain nearly
normal in uremia [121. Antigen responses have also been found
low [3, 13]. These findings of both in vivo and in vitro decreased
antigen responses [14] suggest that accessory cell functions
which initialize activation of T cells could be impaired. One
mechanism could be a decreased production of IL-i by the
accessory cells, This could eventually result in a decreased
proliferation of activated T cells and a lower production of IL-2
as previously found in uremic cell cultures [1—6]. In this study
we take advantage of purified preparations of IL- 1 and IL-2
which have recently become available. We have furthermore
studied accessory cell functions in coculture experiments of
HLA-identicai cell combinations. However, the present results
give little support for a monocyte/macrophage defect. First,
IL- 1 did not reconstitute the patient cell responses whereas
addition of exogenous IL-2 significantly improved the uremic
cell responses. Second, coculture experiment showed that
uremic macrophages/monocytes have the same capacity to
serve as accessory cells for suboptimally stimulated T cells
(Fig. 5). In these experiments a MLC stimulatory effect could
be excluded since HLA-identical MLC negative combinations
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Fig. 3. Mean '4C-thymidine uptake of 5 x 10
peripheral blood mononuclear cells (PBMCs)
stimulated with optimal concentrations of Leu
4 (20 p.1, 1:20). Symbols are: (D) uremic
PBMC cultures (N = 12); (D) normal PBMC
cultures (N = 12). Vertical lines indicate SEM.
Fig. 4. Effect of '4C-thymidine uptake with or without addition of
erythrocytes to uremic and normal peripheral lymphocytes cultures
stimulated with PHA (40 /.Lg/ml). Symbols are: () uremia; (D) control.







Fig. 5. Mean PHA (2 gIml) responses ('4C-thymidine uptake) in
cocultures of isolated T cells from uremic patients with macrophages
from their healthy HLA-D identical relatives, and vice versa. Hatched
columns denote T cells alone or with 1% or 5% uremic macrophages









responses, and previous studies [61 have shown that blocking of
PGE2 production by indomethacin does not normalize the
uremic lymphocyte responses. It cannot, however, be excluded
that a suppressive effect of macrophages may be more pro-
nounced in other lectin systems.
We cannot rule out that functions of other accessory cells are
impaired in uremia. Dendritic cells (DC) are known to be active
accessory cells in mice and in humans [7, 21, 221. DC are plastic
non-adherent cells and are therefore excluded in the present
study by the plastic adherence procedure of the monocytes!
macrophages.
In rare conditions impaired in vitro lymphocyte proliferation
is caused by a deficiency of the enzyme system needed for the
anaerobic glycolysis. This can be reversed by addition of an
exogenous oxygen source [23, 24]. Addition of normal erythro-
cytes as oxygen suppliers improved the mitogen response of
uremic and normal lymphocytes equally well, which show that
the anaerobic condition that prevails in most culture medias
does not especially injure uremic cells.
This and previous studies [5, 12] of immune responses in
uremia confirm that the proliferative capacity of uremic T cells
is impaired. Accessory cell functions as well as cytotoxic
effector cell functions, however, seem normal.
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